1. Home
  2. ZLAB vs CNK Comparison

ZLAB vs CNK Comparison

Compare ZLAB & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CNK
  • Stock Information
  • Founded
  • ZLAB 2013
  • CNK 1984
  • Country
  • ZLAB China
  • CNK United States
  • Employees
  • ZLAB N/A
  • CNK N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CNK Movies/Entertainment
  • Sector
  • ZLAB Health Care
  • CNK Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • CNK Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • CNK 3.1B
  • IPO Year
  • ZLAB 2017
  • CNK 2007
  • Fundamental
  • Price
  • ZLAB $32.58
  • CNK $28.28
  • Analyst Decision
  • ZLAB Buy
  • CNK Buy
  • Analyst Count
  • ZLAB 6
  • CNK 12
  • Target Price
  • ZLAB $57.22
  • CNK $33.67
  • AVG Volume (30 Days)
  • ZLAB 819.9K
  • CNK 3.6M
  • Earning Date
  • ZLAB 11-11-2025
  • CNK 10-30-2025
  • Dividend Yield
  • ZLAB N/A
  • CNK 1.13%
  • EPS Growth
  • ZLAB N/A
  • CNK 86.03
  • EPS
  • ZLAB N/A
  • CNK 1.92
  • Revenue
  • ZLAB $427,799,000.00
  • CNK $3,217,300,000.00
  • Revenue This Year
  • ZLAB $42.62
  • CNK $7.95
  • Revenue Next Year
  • ZLAB $55.12
  • CNK $7.50
  • P/E Ratio
  • ZLAB N/A
  • CNK $14.69
  • Revenue Growth
  • ZLAB 32.56
  • CNK 13.80
  • 52 Week Low
  • ZLAB $20.17
  • CNK $23.12
  • 52 Week High
  • ZLAB $44.34
  • CNK $36.28
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 48.51
  • CNK 62.19
  • Support Level
  • ZLAB $31.68
  • CNK $26.79
  • Resistance Level
  • ZLAB $33.06
  • CNK $28.86
  • Average True Range (ATR)
  • ZLAB 1.34
  • CNK 0.70
  • MACD
  • ZLAB 0.21
  • CNK 0.36
  • Stochastic Oscillator
  • ZLAB 80.97
  • CNK 84.76

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.

Share on Social Networks: